Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the page footer; no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedMinor UI and metadata updates were made: the glossary is now shown, the page revision was updated to v3.4.0, and QC/FEAR Act data labels were added or adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page's Locations section has been updated to include numerous new sites across the United States and international locations (Australia, Canada, Japan, and others). The geographic coverage of listed study sites appears expanded.SummaryDifference2%

- Check88 days agoChange DetectedRevision: v3.3.2 is now shown on the page, updating from v3.3.1 to reflect a minor document revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.